Literature DB >> 1727609

Isolation of matrix protein M1 from influenza viruses by acid-dependent extraction with nonionic detergent.

O P Zhirnov1.   

Abstract

Influenza viruses were disrupted layer by layer with the nonionic detergent NP-40 at fixed pH. Treatment of the virions with NP-40 at neutral or mildly alkaline pH (6.8-8.0) yielded viral core structures containing M1 protein. The matrix M1 protein was selectively extracted from cores at acidic pH 3.0-4.5 with citrate, acetate, and phosphate buffers or with morpholinoethanesulfonic acid. The resulting M1 protein sedimented in a glycerol gradient with a coefficient of 2.8 S and most likely existed as a monomeric form of the 27,000-Da polypeptide. An antigenic map of the monomeric protein M1 tested with a panel of monoclonal anti-M1 antibodies was found to be similar to those of the assembled M1 protein in whole virions. The isolated M1 protein retained biological properties and inhibited the RNA polymerase activity of viral RNP. This transcription-inhibition function of M1 monomers was specifically restricted by one of the monoclonal antibodies studied.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727609     DOI: 10.1016/0042-6822(92)90090-c

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

1.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production.

Authors:  Matthew F McCown; Andrew Pekosz
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 3.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

4.  Solution Structure, Self-Assembly, and Membrane Interactions of the Matrix Protein from Newcastle Disease Virus at Neutral and Acidic pH.

Authors:  E V Shtykova; M V Petoukhov; L A Dadinova; N V Fedorova; V Yu Tashkin; T A Timofeeva; A L Ksenofontov; N A Loshkarev; L A Baratova; C M Jeffries; D I Svergun; O V Batishchev
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane.

Authors:  Juan Fontana; Alasdair C Steven
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

6.  Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited.

Authors:  S J Armstrong; N J Dimmock
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  The in situ spatial arrangement of the influenza A virus matrix protein M1 assessed by tritium bombardment.

Authors:  A V Shishkov; V I Goldanskii; L A Baratova; N V Fedorova; A L Ksenofontov; O P Zhirnov; A V Galkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

8.  In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.

Authors:  Zhiguang Ran; Ying Chen; Huigang Shen; Xiaoxiao Xiang; Qinfang Liu; Bhupinder Bawa; Wenbao Qi; Laihua Zhu; Alan Young; Juergen Richt; Wenjun Ma; Feng Li
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

9.  Influenza B virus BM2 protein is a crucial component for incorporation of viral ribonucleoprotein complex into virions during virus assembly.

Authors:  Masaki Imai; Shinji Watanabe; Ai Ninomiya; Masatsugu Obuchi; Takato Odagiri
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 10.  Influenza virus morphogenesis and budding.

Authors:  Debi P Nayak; Rilwan A Balogun; Hiroshi Yamada; Z Hong Zhou; Subrata Barman
Journal:  Virus Res       Date:  2009-05-27       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.